NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Tirzepatide vendors

Shandong Aishi BiotechnologyTirzepatide

29 testslatest 26 Aug 2026$0.43/mg median
Free peptide testing

Ordered Tirzepatide from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it for free.

Test my supply
+1 more ↓
80%
Finnrick rating
#80 of 200 Tirzepatide vendors
23 of 29 classifiable tests passed
customers 4.7★ (19)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Shandong Aishi's Tirzepatide rating is held down by repeated sub-99.5% purity results and one +56% fill miss, despite a recent pass streak. Check newer passes against the February purity cluster, endotoxin note, and batch-ID gaps.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shandong Aishi Biotechnology

Registry records frame Shandong Aishi as a young sole-owner exporter, while TikTok presents a factory-grade production story. The report traces the ownership, claim gaps, DNS/contact stack, and unresolved penalty flags buyers cannot see from the live stats.

21 pages5 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
95%
14
2
Retatrutide
$0.93
82%
24
3
Tirzepatideselected
$0.43
80%
29
4
Ipamorelin
$1.96
76%
4
5
Tesamorelin
$2.10
47%
6
7
Cagrilintide
$4.40
-
0
8
MOTS-c
-
-
0
9
Semaglutide
$0.65
-
0
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%6 Oct 2025: 73%29 Oct 2025: 70%4 Nov 2025: 71%5 Nov 2025: 72%25 Nov 2025: 73%5 Dec 2025: 75%6 Dec 2025: 76%29 Dec 2025: 77%15 Jan 2026: 79%15 Jan 2026: 80%26 Jan 2026: 82%2 Feb 2026: 77%2 Feb 2026: 73%2 Feb 2026: 70%4 Feb 2026: 71%15 Feb 2026: 73%18 Feb 2026: 73%20 Feb 2026: 74%20 Feb 2026: 75%20 Feb 2026: 72%26 Feb 2026: 73%3 Mar 2026: 74%6 Mar 2026: 75%6 Mar 2026: 76%6 Mar 2026: 77%2 Jun 2026: 78%16 Jun 2026: 79%17 Jun 2026: 79%26 Aug 2026: 80%15 Sept 2026: current 80%73%73%80%Oct 25Sep 26
Showing Tirzepatide tests only
Free peptide testing

Ordered Tirzepatide from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it for free.

Test my supply
Shandong Aishi Biotechnology Tirzepatide test history
COA-backed lab tests
1-10 of 29

About Shandong Aishi Biotechnology test results from Finnrick

Shandong Aishi Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 77 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shandong Aishi Biotechnology peptides in this dataset are GHK-Cu (14 tests), Ipamorelin (4 tests) and Retatrutide (24 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 77 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered Tirzepatide from Shandong Aishi Biotechnology? Mail in a sample (US only) and let us test it for free.

Test my supply